Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Doxycycline and Interferon beta-1a in RRMS
NCT00246324Phase 4Completed
- Sponsor
- LSU Health Shreveport
- Start
- Dec 2003
- Primary completion
- Aug 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of doxycycline in relapsing-remitting multiple sclerosis (RRMS), sponsored by LSU Health Shreveport. Primary endpoint: Gadolinium-enhancing (Gd+) Lesion Number Change at 8 months. Started Dec 2003; status: completed.
02
Drugs
doxycycline
03
Conditions
relapsing-remitting multiple sclerosis (RRMS)
Beyond the preview
Go deeper on NCT00246324.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00246324.